癌变·畸变·突变 ›› 1999, Vol. 11 ›› Issue (5): 275-276.doi: 10.3969/j.issn.1004-616x.1999.05.026

• 交流论文 • 上一篇    

rhEPO 注射液致突变作用研究

胡燕平 李彦红   

  1. 中国药品生物制品检定所 北京 100050
  • 收稿日期:1999-07-30 修回日期:1999-09-15 出版日期:1999-09-30 发布日期:1999-09-30

THE STUDY ON MUTAGENICITY OF rhEPO INJECTIONS

Hu Yanping , Li Yanhong   

  1. National Instit ute f or the Control of Pharmaceutical and Biological Products , Beijing  100050
  • Received:1999-07-30 Revised:1999-09-15 Online:1999-09-30 Published:1999-09-30

摘要: 本文应用Ames 试验和小鼠骨髓嗜多染红细胞微核试验,对三家单位提供的3 个批号rhEPO 注射液进行了致突变作用研究。Ames 试验结果:各受试物的5 个剂量组(18. 75~300. 00IU/ 皿) ,在活化及非活化条件下诱发TA97 、TA98 、TA100、TA102 菌株的回变菌落数未见明显增加;微核试验结果:各受试物在15000~60000IU/ kg 剂量范围内,小鼠骨髓嗜多染红细胞微核率未见明显增加。表明在本试验条件下,3 个批号rhEPO 注射液均无明显致突变作用。

关键词: rhEPO 注射液, Ames 试验, 小鼠骨髓嗜多染红细胞微核试验, 致突变作用

Abstract: Three batches of rhEPO injections were studied on mutagenicity by Ames test and micronucleus test of PCE in mouse bone marrow. The Ames test result s showed that the reversion mutation f requencies of three batches of rhEPO injections with five doses ( 18. 75~300. 00 IU/ plate) didn’t increase in st rain TA97 , TA98 ,TA100 and TA102 with or without S9mix ; In 15000~60000 IU/ kg doses , the f requencies of micronucleus in bone marrow PCE cells of mice didn’tincrease. It showed three batches of rhEPO injections had no mutagenicity.

Key words: rhEPO Injections, Ames test, micronuclues test of PCE in mouse bone marrow, mutagenicity